Establishment of a statewide network for carbapenem-resistant Enterobacteriaceae prevention in a low-incidence region

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 356-361

  Pfeiffer, Christopher D ^a,b   Cunningham, Margaret C ^c   Poissant, Tasha ^c   Furuno, Jon P ^d   Townes, John M ^a   Leitz, Andrew ^b   Thomas, Ann ^c   Buser, Genevieve L ^c   Arao, Robert F ^c   Beldavs, Zintars G ^c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; DISEASE SURVEILLANCE; EDUCATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENVIRONMENTAL MONITORING; HEALTH CARE FACILITY; HEALTH SURVEY; INCIDENCE; INFECTION CONTROL; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DIAGNOSTIC PROCEDURE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; UNITED STATES;

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CLINICAL LABORATORY TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INCIDENCE; OREGON; POPULATION SURVEILLANCE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84895828060     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675605     Document Type: Article

References (19)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53(1):60-67.
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011;17(10): 1791-1798.
3. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45(4):1151-1161.
4. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4(148): 148ra116.
5. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099-1106.
6. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004;101(10):3709-3714.
7. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53(6):532-540.
8. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52(7):848-855.
9. Centers for Disease Control and Prevention. Long-term care assessment tool. http://www.cdc.gov/HAI/toolkits/LTC _Assessment_tool_final.pdf. Accessed November 1, 2012.
10. Centers for Disease Control and Prevention. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): 2012 CRE toolkit. http://www.cdc.gov/hai/pdfs /cre/CRE-guidance-508.pdf. Accessed August 15, 2013.
11. Oregon Health Authority. Guidance for control of carbapenemresistant Enterobacteriaceae (CRE): 2013 Oregon toolkit. http://public.health.oregon.gov/DiseasesConditions/DiseasesAZ /CRE. Accessed August 15, 2013.
12. Patel G, Bonomo RA. "Stormy waters ahead:" global emergence of carbapenemases. Front Microbiol 2013;4:48.
13. Barnes SL, Harris AD, Golden BL, Wasil EA, Furuno JP. Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels. Infect Control Hosp Epidemiol 2011;32(11):1073-1078.
14. The Joint Commission. 2013 comprehensive accreditation manual for hospitals: infection prevention and control standard IC.02.01.01. Oak Brook, IL: Joint Commission Resources, 2013: IC-8-IC-9.
15. Council of State and Territorial Epidemiologists. Communication of possible healthcare-associated infections across healthcare settings. Position statement 13-ID-09. 2013.
16. Roup BJ, Scaletta JM. How Maryland increased infection prevention and control activity in long-term care facilities, 2003-2008. Am J Infect Control 2011;39(4):292-295.
17. Gamage B, Schall V, Grant J, Group PIL-tCNAW. Identifying the gaps in infection prevention and control resources for longterm care facilities in British Columbia. Am J Infect Control 2012; 40(2):150-154.
18. Roup BJ, Roche JC, Pass M. Infection control program disparities between acute and long-term care facilities in Maryland. Am J Infect Control 2006;34(3):122-127.
19. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twentysecond informational supplement. CLSI document M100-S22. Wayne, PA: CLSI, 2012.